Article
Envision Pharma Group
3 KEY Factors that Altered the MSL Role Since 2020
Summary
Join Mitchell D’Rozario and Tom Caravela as they celebrate the podcast's 3-year anniversary by exploring three key factors transforming the MSL role since 2020. They discuss the shift to virtual engagement, the evolution of MSLs from scientific messengers to strategic thinkers, and the integration of AI technologies like ChatGPT in medical affairs. The episode also reflects on insights from past guests, evolving hiring practices post-COVID-19, and the growing influx of clinicians into MSL positions. Tune in for predictions on future trends in the MSL landscape.
This episode features Mitchell D’Rozario, Sr Medical Science Liaison at Genentech discusses 3 ways the MSL role has changed since March of 2020
We discuss….
👉 What was the “silver lining” from COVID
👉 How virtual engagement has emerged and what MSLs can do better
👉 Why MSLs are the “curators of knowledge” and “oracles of information”
👉 The importance of authenticity
👉 What’s next for the MSL role
MSL role evolution, virtual engagement, strategic thinkers, AI in medical affairs, post-COVID hiring practices
Related Topics
You May Also Like
Envision Pharma Group
Podcast
MSL Talk: Tom Caravela, Paul Ward
How Medical Affairs Professionals Should Engage with Digital Opinion Leaders
Podcast
MSL Talk: Tom Caravela, Patrina Pellett
Fierce Pharma Engage 2025 - RECAP
Article
Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
Article
Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
Article
Vanessa Arciero, BS, Seanthel Delos Santos, Liza Koshy